Health regulator gears up for transition to licensing of medical devices
IANS 15 September 2022
The reconstituted National Medical Device Promotion Council (NMDPC) under the Department of Pharmaceuticals held its first meeting in New Delhi and was updated on the steps taken up by Central Drugs Standard Control Organisation (CDSCO) and the state licensing authorities for the smooth transition to licensing of class-A and class-B medical devices from October 1.
 
The NMDPC deliberated on the important issues of the Medtech (medical technology) industry.
 
The Council under the chair of the Secretary, Department of Pharmaceuticals, has members from stakeholder departments, organisations, functions of which have a bearing on the growth of the sector and has representation from several medical device industry associations, representing the sector in India.
 
The Department of Pharmaceuticals presented the latest status of the various initiatives taken by it for the sector to the Council such as 100 per cent FDI in MedTech sector on automatic route, PLI scheme for medical devices, medical devices parks in four states, assistance for common infrastructure facility of superconducting magnetic coil testing facility, etc.
 
The Department of Health and Family Welfare (DoHFW) updated the preparedness for transition to licensing of class-A and class-B medical devices from October 1 under Medical Devices Rules, 2017. The Council appreciated the various efforts done by the CDSCO/DoHFW in rolling out the licensing process of class-A and class-B medical devices.
 
The Council also heard the views of the industry as well as AERB (Atomic Energy Regulatory Board) and National Accreditation Board for Testing and Calibration Laboratories (NABL) on the requirement of NABL accreditation of in-house laboratories of the manufacturers of specific medical devices on the radiation safety requirements at the manufacturing sites. The industry suggested various issues to be taken up in the subsequent Council meeting.
 
The Industry Associations' representatives were encouraged to actively engage with states, which were sanctioned medical devices parks by the Department of Pharmaceuticals for creating common infrastructure facilities and come forward to invest in the proposed parks to boost domestic manufacturing.
 
The industry's support was also solicited for the proposed National MedTech Expo, 2022, being organised by the Department in December 2022 at New Delhi's Pragati Maidan to showcase the strengths and capabilities of Indian medical devices industry involving start-ups, innovators, domestic manufacturers, hospitals etc.
 
Disclaimer: Information, facts or opinions expressed in this news article are presented as sourced from IANS and do not reflect views of Moneylife and hence Moneylife is not responsible or liable for the same. As a source and news provider, IANS is responsible for accuracy, completeness, suitability and validity of any information in this article.
Comments
Corona Virus (COVID-19) Latest Updates
IANS 27 September 2022
India reports 3,230 fresh COVID cases, 32 deaths in past 24 hours
27-09-2022 10:50

India has reported 3,230 fresh Covid infections and 32 deaths in the last 24 hours, the Union Health Ministry said on Tuesday.

With the...
Indians using OTC antibiotics at will, Azithromycin most abused: Lancet study
IANS 07 September 2022
A Lancet study has raised major concerns over the rampant use of over-the-counter (OTC) antibiotics in India, saying that most of these drugs have not been approved by the central drug regulator that has resulted in severe...
Corona Virus (COVID-19) Latest Updates
IANS 30 August 2022
India records 5,439 fresh COVID cases, active cases below 70,000 mark
30-08-2022 11:20

India on Tuesday witnessed a decline in Covid cases with 5,439 fresh infections reported in the last 24 hours, against previous day's...
Johnson & Johnson To Stop Selling and Making Talc-based Baby Powder Globally
IANS 12 August 2022
Johnson & Johnson is to stop selling and making talc-based baby powder globally, two years after it ended sales in the US and Canada, the media reported.
 
The healthcare firm has faced tens of thousands of lawsuits from...
Free Helpline
Legal Credit
Feedback